Blood test aims to personalize cancer care, reduce harsh side effects
NCT ID NCT03844620
Summary
This study is testing if a simple blood test can help doctors choose the best treatment for patients with advanced colorectal cancer that has spread. The test looks for tiny pieces of tumor DNA in the blood. Researchers want to see if using this test to guide treatment leads to fewer severe side effects and better quality of life compared to the standard way of choosing treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III COLORECTAL CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.